GB1243383A - Manufacturing adsorbed vaccines - Google Patents
Manufacturing adsorbed vaccinesInfo
- Publication number
- GB1243383A GB1243383A GB44534/68A GB4453468A GB1243383A GB 1243383 A GB1243383 A GB 1243383A GB 44534/68 A GB44534/68 A GB 44534/68A GB 4453468 A GB4453468 A GB 4453468A GB 1243383 A GB1243383 A GB 1243383A
- Authority
- GB
- United Kingdom
- Prior art keywords
- manufacturing
- vaccines
- sept
- aqueous solution
- adsorbed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000000427 antigen Substances 0.000 abstract 2
- 102000036639 antigens Human genes 0.000 abstract 2
- 108091007433 antigens Proteins 0.000 abstract 2
- 239000007864 aqueous solution Substances 0.000 abstract 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 abstract 1
- 239000001110 calcium chloride Substances 0.000 abstract 1
- 229910001628 calcium chloride Inorganic materials 0.000 abstract 1
- 229940061607 dibasic sodium phosphate Drugs 0.000 abstract 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR122284 | 1967-09-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1243383A true GB1243383A (en) | 1971-08-18 |
Family
ID=8638987
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB44534/68A Expired GB1243383A (en) | 1967-09-26 | 1968-09-19 | Manufacturing adsorbed vaccines |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US3608071A (enExample) |
| AT (1) | AT282822B (enExample) |
| BE (1) | BE721141A (enExample) |
| CH (1) | CH492786A (enExample) |
| DE (1) | DE1792600A1 (enExample) |
| DK (1) | DK122970B (enExample) |
| FR (1) | FR1604134A (enExample) |
| GB (1) | GB1243383A (enExample) |
| LU (1) | LU56939A1 (enExample) |
| NL (1) | NL6813543A (enExample) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2181426B1 (enExample) * | 1972-04-06 | 1974-12-20 | Pasteur Institut | |
| US4016252A (en) * | 1972-04-06 | 1977-04-05 | Institut Pasteur | Calcium phosphate gel for adsorbing vaccines |
| US4070454A (en) * | 1973-05-04 | 1978-01-24 | Agence Nationale De Valorisation De La Recherche (Anvar) | Vaccines, the process for preparing the same and the applications thereof |
| FR2227861B1 (enExample) * | 1973-05-04 | 1976-07-02 | Anvar | |
| US3874999A (en) * | 1973-10-31 | 1975-04-01 | American Cyanamid Co | Process for the purification of virus vaccine |
| US3978209A (en) * | 1975-03-24 | 1976-08-31 | Merck & Co., Inc. | Endotoxin free meningococcus polysaccharides |
| DE2843963A1 (de) * | 1978-10-09 | 1980-04-24 | Merck Patent Gmbh | Im koerper resorbierbare geformte masse auf basis von kollagen und ihre verwendung in der medizin |
| DE2807132C2 (de) * | 1978-02-20 | 1983-11-03 | Battelle-Institut E.V., 6000 Frankfurt | Implantierbares Pharmaka-Depot |
| US4273762A (en) * | 1979-12-03 | 1981-06-16 | Merck & Co., Inc. | Lyophilization process for live viral compositions |
| US5101019A (en) * | 1987-05-22 | 1992-03-31 | Takeda Chemical Industries, Ltd. | Method for removing pertussis endotoxin, a pertussis toxoid and its production |
| US8333996B2 (en) | 1995-05-19 | 2012-12-18 | Etex Corporation | Calcium phosphate delivery vehicle and adjuvant |
| US8728536B2 (en) * | 1996-10-16 | 2014-05-20 | Etex Corporation | Chemotherapeutic composition using nanocrystalline calcium phosphate paste |
| EP1615596B1 (en) * | 2003-04-11 | 2016-11-02 | Etex Corporation | Osteoinductive bone material |
| AU2004249802B2 (en) * | 2003-06-20 | 2007-06-28 | Microbix Biosystems Inc. | Improvements in virus production |
| KR101218454B1 (ko) * | 2004-04-15 | 2013-01-04 | 에텍스 코포레이션 | 세팅 지연 칼슘 포스페이트 페이스트 |
| US8147860B2 (en) | 2005-12-06 | 2012-04-03 | Etex Corporation | Porous calcium phosphate bone material |
-
1967
- 1967-09-26 FR FR122284A patent/FR1604134A/fr not_active Expired
-
1968
- 1968-09-10 CH CH1357868A patent/CH492786A/fr not_active IP Right Cessation
- 1968-09-19 GB GB44534/68A patent/GB1243383A/en not_active Expired
- 1968-09-20 US US761278A patent/US3608071A/en not_active Expired - Lifetime
- 1968-09-20 BE BE721141D patent/BE721141A/xx not_active IP Right Cessation
- 1968-09-20 AT AT917868A patent/AT282822B/de not_active IP Right Cessation
- 1968-09-21 NL NL6813543A patent/NL6813543A/xx unknown
- 1968-09-23 LU LU56939A patent/LU56939A1/xx unknown
- 1968-09-24 DE DE19681792600 patent/DE1792600A1/de active Pending
- 1968-09-25 DK DK461368AA patent/DK122970B/da not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US3608071A (en) | 1971-09-21 |
| DK122970B (da) | 1972-05-01 |
| AT282822B (de) | 1970-07-10 |
| LU56939A1 (enExample) | 1969-01-04 |
| DE1792600A1 (de) | 1971-11-25 |
| NL6813543A (enExample) | 1969-03-28 |
| CH492786A (fr) | 1970-06-30 |
| BE721141A (enExample) | 1969-03-03 |
| FR1604134A (enExample) | 1971-07-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1422973A (en) | Process for preparing adsorbed vaccines | |
| IE41064B1 (en) | Peptides having lh-rh/fsh-rh activity and process for preparing them | |
| GB1501724A (en) | Highly attenuated cytomegalovirus vaccine and production thereof | |
| BE768404A (fr) | Procede de preparation de pigments d'oxyde de fer et d'oxyde defer hydrate | |
| GB1292803A (en) | Improvements relating to the production of antigens | |
| ES434461A1 (es) | Procedimiento para la preparacion de fluoruro de calcio a partir de acido hexafluosilicico. | |
| CA958333A (en) | Process of preparing aqueous suspension of chloramphenicol palmitate | |
| GB1351006A (en) | Water-soluble konjac mannan and a process for the preparation thereof | |
| GB1243252A (en) | Stable poliomyelitis vaccines and process for their manufacture | |
| GB1316740A (en) | Preparation of calcododecalactam | |
| BE770245A (fr) | Procede de preparation de dichlorures d'acrylisonitriles et de chlorures d'acides dicarboxyliques | |
| CA922691A (en) | Process for the preparation of 21-deoxy-21-n-/n' -methylpiperazinyl/ -prednisolone and salts | |
| GB1301468A (enExample) | ||
| BE776753A (fr) | Procede de preparation de l'acide acrylique et de l'acide methacryliqu | |
| GB1240130A (en) | Slow-release adsorbed allergens | |
| GB1357926A (en) | Concentrated antacid composition | |
| GB1241464A (en) | PREPARATION OF PENTACALCIUM ORTHOPERIODATE, Ca5(IO6) 2, USEFUL IN A SALT BLOCK AND FEEDS | |
| ZA712711B (en) | Process for the preparation of alive varicella virus useful as an antigen in a vaccine | |
| CA971165A (en) | Process for preparing 3-aminopropylester of bleomycinic acid | |
| GB1396817A (en) | Diagnostic preparations comprising 99m technetium | |
| GB1136143A (en) | Method of preparing anthraxin | |
| GB1441375A (en) | Injectable solutions for the treatment of rheumatism and of other diseases | |
| AU3710671A (en) | Process of preparing aqueous suspension of chloramphenicol palmitate | |
| GB1394559A (en) | 2-methoxy-5-alkylsulphonyl benzamides | |
| GB1189577A (en) | Production of N-Acetyl-3-(3,4-Methylenedioxyphenyl)-L-Alanine |